Man Clones Himself to Test Anti-Aging Therapies

Bryan Johnson recently claimed on X to have "cloned himself as a newborn," initiating a significant discussion regarding advanced health and anti-aging technologies. Johnson stated his intention to use this cellular "clone" to test therapies, grow organs for transplantation, and develop new treatments by injecting younger cells. He detailed the process as extracting his cells, applying Yamanaka factors to reset their epigenetic age, and making them pluripotent for rebuilding the body.

However, experts have clarified that Johnson did not create a human clone. What he described is the generation of induced pluripotent stem cells (iPSCs) from his adult cells, which can develop into many specialized cell types but do not form a new human organism. Human cloning is not currently feasible. While some iPSC applications are entering early clinical practice, such as in ophthalmology, many remain experimental for conditions like Parkinson's disease or spinal cord injuries.

The advancement of regenerative medicine highlights the distinction between genuine scientific breakthroughs and public misunderstanding. Dr. Palleti Siva Karthik Reddy explained that while iPSCs represent a major breakthrough for research, they are reprogrammed cells, not cloned individuals. The scientific community emphasizes that claims about routinely rebuilding the body organ by organ are not yet supported by current clinical evidence, underscoring the need for well-conducted human clinical trials to prove safety and effectiveness.